OrthoPediatrics’ (KIDS) “Buy” Rating Reiterated at Needham & Company LLC

OrthoPediatrics (NASDAQ:KIDS)‘s stock had its “buy” rating reissued by equities research analysts at Needham & Company LLC in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $42.00 price target on the stock. Needham & Company LLC’s price target would indicate a potential upside of 83.49% from the company’s previous close.

Separately, Truist Financial decreased their price objective on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a report on Wednesday, December 18th.

OrthoPediatrics Price Performance

Shares of KIDS stock opened at $22.89 on Wednesday. The firm’s 50 day moving average price is $24.39 and its two-hundred day moving average price is $25.94. The stock has a market cap of $554.30 million, a PE ratio of -18.61 and a beta of 1.14. OrthoPediatrics has a 52-week low of $21.02 and a 52-week high of $35.99. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings data on Tuesday, March 4th. The company reported ($0.29) EPS for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.04. OrthoPediatrics had a negative return on equity of 5.78% and a negative net margin of 15.00%. The business had revenue of $52.67 million during the quarter, compared to the consensus estimate of $51.16 million. During the same quarter in the prior year, the company posted ($0.23) earnings per share. As a group, analysts forecast that OrthoPediatrics will post -0.93 EPS for the current year.

Institutional Investors Weigh In On OrthoPediatrics

A number of hedge funds have recently modified their holdings of the business. Quarry LP acquired a new position in shares of OrthoPediatrics in the 3rd quarter valued at approximately $25,000. International Assets Investment Management LLC lifted its stake in OrthoPediatrics by 2,610.8% in the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after buying an additional 966 shares in the last quarter. R Squared Ltd acquired a new position in shares of OrthoPediatrics in the fourth quarter valued at approximately $48,000. KLP Kapitalforvaltning AS bought a new stake in shares of OrthoPediatrics during the fourth quarter worth $79,000. Finally, BNP Paribas Financial Markets raised its holdings in shares of OrthoPediatrics by 125.1% during the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock worth $94,000 after acquiring an additional 1,929 shares during the period. Institutional investors and hedge funds own 69.05% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.